Willis C. Lee - Sep 8, 2021 Form 4 Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Role: Vice Chairman & COO, Director
Signature: Willis C. Lee
Stock symbol: EMMA
Transactions as of: Sep 8, 2021
Transactions value $: $6,840
Form type: 4
Date filed: 9/10/2021, 06:17 PM
Previous filing: Aug 27, 2021
Next filing: Sep 17, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EMMA	Common stock, $0.001 par value	Purchase	$3.4K	+2K	+1.84%	$1.70^*	111K	Sep 8, 2021	By Fidelity Traditional IRA FBO Willis C. Lee	F1
transaction	EMMA	Common stock, $0.001 par value	Purchase	$3.44K	+2K	+1.81%	$1.72^*	113K	Sep 10, 2021	By Fidelity Traditional IRA FBO Willis C. Lee	F2
holding	EMMA	Common stock, $0.001 par value						256K	Sep 8, 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.65 to $1.75, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (2) to this Form 4.
F2	The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.67 to $1.77, inclusive.

Content

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.65 to $1.75, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (2) to this Form 4.

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.67 to $1.77, inclusive.